Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

PHENOtyping targeted single-cell via integrated digital microfluidics and optoelectronic tweezerS

Project description

Tracking rogue cancer cells to predict tumour progression and resistance

Tumours are not uniform masses but chaotic ecosystems composed of vastly different cells. Within a single tumour, specific cell subpopulations can often drive cancer progression, cause metastasis and resist treatments. Their identification is challenging because traditional diagnostic tools look at the tumour as a whole, masking individual cellular behaviour. Supported by the Marie Skłodowska-Curie Actions programme, the PHENOS project will combine engineering, biology, chemistry and computational science to isolate and analyse these individual cancer cells. Researchers plan to develop the first hybrid platform that will combine microfluidic fluid channels for liquid handling, optoelectronic tweezers for non-invasive manipulation and data analysis algorithms for high-resolution phenotypic profiling. If successful, the platform will capture and track single cells with over 95 % accuracy.

Objective

Cellular populations are rich in diversity, and understanding this heterogeneity at the single-cell level is crucial in oncology, where specific subpopulations can drive tumour progression, metastasis, and therapy resistance. PHENOS (“PHENOtyping targeted single-cell via integrated digital microfluidics and optoelectronic tweezerS”) addresses this challenge by introducing the first hybrid platform for targeted single-cell analysis and manipulation. The system combines digital microfluidics (DMF) for precise liquid handling, aptamer-mediated cell surface functionalization for molecular targeting, optoelectronic tweezers (OET) for non-invasive manipulation, and advanced data analysis algorithms for high-resolution phenotypic profiling.
The project is structured in four phases: (1) design and validation of DMF and OET devices, (2) integration into a hybrid opto-microfluidic platform, (3) targeted cell functionalization and longitudinal phenotyping through time-lapse imaging, and (4) development of machine learning and deep learning algorithms for classification and phenotypic stratification.
Through a comprehensive and synergistic training programme bridging engineering, biology, chemistry, and computational science, PHENOS will: (1) establish a dynamic, high-precision workflow for single-cell measurement and sorting, and (2) enhance OET sensitivity and specificity, achieving ≥95% classification accuracy, in independent experiments, with an expected 20% gain from aptamer targeting. By overcoming current limitations, PHENOS will establish a novel framework for decoding cellular heterogeneity in cancer with a decision-making process, guiding personalised treatments and improving patient outcomes, while providing me a unique multidisciplinary environment to build scientific independence and long-term leadership.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-GF - HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Net EU contribution
€ 317 923,08
Address
VIA CRACOVIA 50
00133 Roma
Italy
Region
Centro (IT) Lazio Roma
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)